Thursday, November 14, 2019
Workshop A: Continuous Glucose Monitoring
Panel 1: Technical
8:00
Moderator
8:05
Technology to Improve Performance
Peter Simpson, MS
Dexcom, San Diego, California
8:20
Technology to Improve Performance
Andrea Varsavsky
Medtronic Diabetes, Los Angeles, California
8:35
Technology to Improve Performance
Yanan Zhang
Zhejiang POCTech Co., Ltd. Huzhou, China
8:50
Technology to Improve Performance
TBD
Abbott Diabetes Care, Alameda, California
9:05
Technology to Improve Performance
Alex Ghesquiere
Senseonics, Germantown, Maryland
9:20
Q & A
9:35
Break
Panel 2: Interstitial Fluid
9:55
Moderators
10:00
Interstitial Fluid Physiology
Sanjiv Sharma
American Diabetes Association, Arlington, Virginia
10:15
Limitations of Current Transdermal CGM Devices from a Tissue Perspective
Ulrike Klueh, PhD
Wayne State University, Detroit, Michigan
10:30
Sampling Interstitial Fluid from Skin Using a Microneedle Patch
Mark Prausnitz, PhD
Georgia Institute of Technology, Atlanta, Georgia
10:45
Harvesting and Assaying ISF Using Microneedles
Philip Mach, PhD, MRSC
US Army, Aberdeen Proving Ground, Maryland
11:00
Q & A
11:30
End of workshop/Lunch
Workshop B: Diabetic Complications: Success and Failure
Panel 1: Success with Foot Ulcers
8:00
Moderator
8:05
NIH Programs for Diabetes Foot Wound Technology
Teresa Jones, PhD
National Institutes of Health, Bethesda, Maryland
8:20
Will Smart Technologies Make Our Treatment Smarter? – The Promise and barriers of digital health to manage diabetic foot complications
Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas
8:35
Smart Shoes and Diabetic Foot Ulcer Prevention
Davide Vigano
Sensoria Inc., Redmond, Washington
8:50
Smart Mat Platform and Prevention of Diabetic Foot Ulcers
Jon Bloom, MD
Podimetrics, Cambridge, Massachusetts
9:05
Q & A
9:35
Break
Panel 2: Overcoming Barriers
9:55
Moderator
10:00
Hypoglycemia Alarms
Bruce Buckingham, MD
Stanford University, Palo Alto, California
10:15
Insulin Pump Occlusion
Guido Freckmann, MD
Institute for Diabetes Technology GmBH, Ulm, Germany
10:30
Modeling CGM or AP Failure
Eyal Dassau, PhD
Harvard University, Cambridge, Massachusetts
10:45
Local Temperature Control of Insulin Absorption
Gabriel Bitton, PhD, MS
InsuLine Medical Ltd, Petah Tikva, Israel
11:00
Q & A
11:30
End of workshop/Lunch
Workshop C: Digital Health
Panel 1: Insulin Dosing
12:30
Moderator
12:35
Potential Benefits of Smart Insulin Pens
David Kerr, MD
Sansum Diabetes Research Institute, Santa Barbara, California
12:55
Insulin optimization using decision support systems for healthcare providers
Moshe Phillip, MD
Schneider Children's Medical Center, Petah Tikva, Israel
13:15
Insulin Pen Technology
Anders Toft, MD, PhD, eMBA
Novo Nordisk, Copenhagen, Denmark
13:35
TBD
TBD
Eli Lilly
13:55
Q & A
14:05
Break
Panel 2: Lifestyle
14:25
Moderator
14:30
Topic Related to the Session's Theme
Korey Hood, PhD
Stanford University, Palo Alto, California
14:45
Using Digital Health to Increase Adherence
Kimberly Driscoll
University of Florida, Gainesville, Florida
15:00
Topic Related to the Session's Theme
TBD
Sanofi
15:15
Cybersecurity of Medical Devices
Aiman Abdel-Malek, PhD
Thirdwayv Inc., Irvine, California
15:30
Q & A
16:00
End of workshop
16:30
Poster Session Night One and Startup Showcase and Inauguration of the 19th Annual Diabetes Technology Meeting
18:15
Posters remain on display for viewing
Workshop D: Blood Glucose Monitoring: What is its Future?
Panel 1: Glucose Data
12:30
Moderator
12:35
Strategies to Enhance the Value of Glucose Data: Integrating - Sharing - Expanding Access
Rolf Hinzmann, MD, PhD
Roche Diagnostics, Mannheim, Germany
12:50
The Need for a Standard for Color-Coded Blood Glucose Values
Larry Katz, PhD
LifeScan, Wayne, Pennsylvania
13:05
Glycemic Variability Metrics: Comparison of SMBG and CGM
David Rodbard, MD
Biomedical Informatics Consultants LLC, Potomac, Maryland
13:20
Glucose Meter Adverse Events
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, Massachusetts
13:35
Q & A
14:05
Break
Panel 2: The Future
14:25
Moderator
14:30
Debate: does SMBG have a future?
Nick Argento, MD, CDTC
Maryland Endocrine and Diabetes, Columbia, Maryland
Timothy Bailey, MD, FACE, FACP, CPI
AMCR Institute, Escondido, California
15:20
New Technology for BGM
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
15:35
New Technology for BGM
John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, England
15:50
Importance of Cybersecurity for BGMs
Kripa Gaonkar
Ascensia Diabetes Care, Tarrytown, New York
16:05
Q & A
16:25
End of workshop
16:30
Poster Session Night One and Startup Showcase and Inauguration of the 19th Annual Diabetes Technology Meeting
18:15
Posters remain on display for viewing
Friday, November 15, 2019
7:00
Continental Breakfast
Session 1: Biosensing and Diabetes Data Science
8:00
Welcome/Opening Remarks
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
University of California, San Francisco, San Francisco, California
8:05
KEYNOTE: Research Opportunities for Diabetes Using Bioengineered Tools
Bruce Tromberg, PhD
Director, National Institute of Biomedical Imaging and Bioengineering, Bethesda, Maryland
8:30
Moderator
8:35
Optimizing glycemic outcomes through new biosensors, machine learning, and adaptive control
Peter Jacobs, PhD
Oregon Health and Science University, Portland, Oregon
8:50
Accelerating Product Innovation Via Simulation
Stephen Patek, PhD
Dexcom, Charlottesville, Virginia
9:05
Using Big Data for Diabetes Technology Research
Ashutosh Sabharwal, PhD
Rice University, Houston, Texas
9:20
Q & A
9:40
Break
Session 2: Regulation of Diabetes Technology
10:05
Moderator
10:10
MAUDE Database
Kristen Pluchino
United States Food and Drug Administration, Silver Spring, Maryland
10:20
Real World Evidence for Clinical Trials
Yiduo Wu
United States Food and Drug Administration, Silver Spring, Maryland
10:30
Interoperable Devices-CGM and ARE designation
Alain Silk, PhD
United States Food and Drug Administration, Silver Spring, Maryland
10:40
Cybersecurity
TBD
United States Food and Drug Administration, Silver Spring, Maryland
10:50
SaMD/ Precertification Program
Marisa Cruz, MD
United States Food and Drug Administration, Silver Spring, Maryland
11:00
Topic Related to the Session's Theme
Yarmela Pavlovic, JD
Hogan Lovells, San Francisco, California
11:10
Q & A
11:35
End of Session/Lunch
Session 3: CGM Data Analysis
12:35
Moderator
12:40
Time in Range: A Critical Appraisal
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
12:55
The Importance of Time-in-Range in Assessing Glycemic Control
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota
13:10
CGM Data Structure and Analysis of Time-in-Range and Other Metrics of Glycemic Control
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia
13:25
FDA Perspective on CGM-based Biomarkers
Courtney Lias, PhD
United States Food and Drug Administration, Silver Spring, Maryland
13:35
Q & A
Session 4: Artificial Pancreas
13:45
Moderator
13:50
Artificial Pancreas Award
13:55
An Overview of Recent Studies
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia
14:05
Project Nightlight
Sue Brown, MD
University of Virginia, Charlottesville, Virginia
14:15
CamAPS FX – taking forward Cambridge artificial pancreas experience
Roman Hovorka, PhD
University of Cambridge, Cambridge, United Kingdom
14:25
New Technology
Ali Dianaty, MBA, MS
Medtronic Diabetes, Northridge, California
14:35
Closed Loop Without a Meal Announcement
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois
14:45
Did we get what we ordered? Insulin, infusion lines, modeling and control
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
14:55
Q & A
15:10
End of Session/Break
Session 5: How to Increase Use of CGM
15:35
Moderator
15:40
How to Increase Use of CGM
Roy Beck, MD, PhD
JAEB Center for Health Research, Tampa, Florida
Sabina Furber, MD
Ascensia Diabetes Care, Basel Switzerland
Francine Kaufman, MD
Senseonics, Germantown, Maryland
David Price, MD
Dexcom, San Diego, California
Robert Vigersky, MD
Medtronic Diabetes, Washington, DC
16:15
Q & A
16:25
End of Session
16:30
Poster Session Night Two and Startup Showcase
18:30
Posters remain on display for viewing
Saturday, November 16, 2019
7:00
Continental Breakfast
Session 6: Novel Insulins
8:00
Moderator
8:05
Welcome/Recap of First Day and Presentation of Student Award
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
University of California, San Francisco, San Francisco, California
8:10
Gold Prize Student Presentation
TBD
8:25
Novel Glucagon Formulations
Jessica Castle, MD
Oregon Health Sciences University, Portland, Oregon
8:45
Future Insulins. Gazing into a crystal ball
Tim Heise, MD
Profil, Neuss, Germany
9:05
An Ultra-stable Single Chain Insulin Analog
Michael Weiss, MD
Case Western University, Cleveland, Ohio
9:25
Hepatic Directed Insulin
Doug Muchmore, MD
Diasome, Cleveland, Ohio
9:45
Q & A
10:05
Break
Session 7: Novel Insulin Delivery Technology
10:25
Moderators
Technologies for improved insulin delivery is necessary, but is it sufficient?
David Harlan, MD
University of Massachusetts, Worcester, Masschsetts
10:40
Smart Insulin
Sanjoy Dutta, PhD
JDRF, New York, New York
10:55
An insulin pill that delivers: Micro-injections in the gut
Alex Abramson, PhD
Stanford University, Palo Alto, California
11:10
Inhaled Insulin
David Kendall, MD
Mannkind Corporation, Thousand Oaks, California
11:25
Critical Factors for Insulin Delivery: Towards an Understanding of Uptake Variability
Ron Pettis, PhD
BD, Research Triangle Park, North Carolina
11:40
Q & A
12:00
End of session/Lunch
Session 8: Disposal of Waste from Diabetes Products
13:00
Moderator
13:05
Waste and Diabetes-Technology: A call for action
Lutz Heinemann, PhD
Science & Co., Düsseldorf, Germany
13:20
Global burden of diabetes.....from an environmental perspective
Ed Krisiunas, MPH
WNWN International, Burlington, Connecticut
13:35
Challenges for a Manufacturer to Reduce Waste Production
Tobias Stumpe
Convatec, Copenhagen, Denmark
13:50
Q & A
Session 9: Hot Topics
14:05
Moderators
14:10
Environmental Causes of Diabetes
Sultan Ayoub Meo, MD, PhD, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia
14:25
Hypoglycemia reduction as an end point for trials of diabetes products
Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia
14:40
A New Mathematical Link Between A1C and Blood Glucose
Yongjin Xu, PhD
Abbott Diabetes Care, Alameda, California
14:55
Q & A
15:10
Break
Session 10: Do It Yourself
15:35
Moderators
15:40
Factors Affecting Support of DIY Systems in Routine Clinical Care
Katharine Barnard, PhD
Bournemouth University, Hampshire, United Kingdom
15:55
The Bleeding Edge: open source algorithms, research, and what's next
Dana Lewis
OpenAPS, Seattle, Washington
16:10
Q & A
Session 11: Live Demonstrations
16:20
Moderator
16:25
Outcomes: Mobile-enabled Food Logging Is Associated With Improved Glycemic Management In The Real-world
Ricardo Abad
Glooko, Inc., Mountain View, California
Glooko Mobile App and Pop Tracker with Real Data and Focus on Food Entry
Jeff Chang
Glooko, Inc., Mountain View, California
16:40
Duodenal Mucosal Resurfacing
TBD
Fractyl Laboratories, Inc., Lexington, Massachusetts
16:55
Concluding Remarks
17:00
Adjourn